AI-generated summary
The authors report an open-label, four-week pilot study of seven patients with treatment-resistant depression who received a daily 2-minute near-infrared light treatment on the forehead. Depression scores on the Hamilton Depression Rating Scale fell after four weeks, and the authors describe the device as promising. The abstract notes the very small sample and the lack of a control group.
- Participants
- 7
- Who or what was studied
- Seven right-handed patients with treatment-resistant depression
- Wavelengths
- 850 nm
- Limits stated in the abstract
- The abstract describes a preliminary, open-label study with only seven patients and no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Depression, Near-infrared, Photobiomodulation, Irradiance, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.